ROHTO PHARMACEUTICAL CO.,LTD. Logo

ROHTO PHARMACEUTICAL CO.,LTD.

Manufactures OTC drugs, skincare, and cosmetics with a focus on eye and dermatological health.

4527 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
大阪市生野区巽西1丁目8番1号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Rohto Pharmaceutical Co., Ltd. is a multinational company that manufactures and markets pharmaceutical products, cosmetics, and functional foods. Its core business centers on over-the-counter (OTC) drugs and skincare, with a significant focus on eye care and dermatological products. The company's portfolio includes a wide range of health and beauty care items. Committed to innovation, Rohto actively engages in research and development, conducting clinical trials for new therapeutic agents and leveraging advanced technologies to develop novel health solutions. The company's mission is to support the physical and mental health of people worldwide, contributing to the overall well-being of individuals and society.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-11 04:04
Registration Form
訂正確認書
Japanese 9.3 KB
2025-07-11 04:03
Annual Report
訂正有価証券報告書-第89期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2025-07-01 02:29
Regulatory News Service
臨時報告書
Japanese 30.2 KB
2025-06-25 02:08
Governance Information
内部統制報告書-第89期(2024/04/01-2025/03/31)
Japanese 26.7 KB
2025-06-25 02:07
Registration Form
有価証券報告書-第89期(2024/04/01-2025/03/31)
Japanese 1.9 MB
2025-06-25 02:07
Registration Form
確認書
Japanese 9.4 KB
2025-05-12 03:40
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.0 KB
2025-04-14 02:15
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.0 KB
2025-03-14 01:44
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.1 KB
2025-02-27 03:52
Share Issue/Capital Change
訂正臨時報告書
Japanese 37.8 KB
2025-02-26 08:00
Share Issue/Capital Change
臨時報告書
Japanese 44.8 KB
2025-02-13 02:46
Major Shareholding Notification
大量保有報告書
Japanese 38.2 KB
2024-11-14 02:17
Interim Report
確認書
Japanese 9.5 KB
2024-11-14 02:16
Interim Report
半期報告書-第89期(2024/04/01-2025/03/31)
Japanese 290.6 KB
2024-07-01 08:37
Regulatory News Service
臨時報告書
Japanese 28.7 KB

Automate Your Workflow. Get a real-time feed of all ROHTO PHARMACEUTICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ROHTO PHARMACEUTICAL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ROHTO PHARMACEUTICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
bioMérieux Logo
Provides in vitro diagnostic solutions for clinical and industrial microbiology.
France BIM
BioPorto Logo
IVD company developing NGAL biomarkers for early acute kidney injury (AKI) risk assessment.
Denmark BIOPOR
Biosergen AB Logo
Developing novel antifungal drugs for life-threatening infections in immunocompromised patients.
Sweden BIOSGN
Bio Solution Co.,Ltd. Logo
Develops cell therapies for degenerative diseases and supplies bio-lab reagents for R&D.
South Korea 086820
Biosynex Logo
European manufacturer of rapid diagnostic tests for professionals and consumer self-tests.
France ALBIO
Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany BIO3
Biotika A.S. Logo
Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.
Slovakia BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom BVXP
Bioversys N Logo
Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.
Switzerland BIOV

Talk to a Data Expert

Have a question? We'll get back to you promptly.